Results 21 to 30 of about 44,798 (290)

Before and Beyond COVID-19: The Interplay of Corruption, Logistics, and Economic Growth in the EU through the RBV Lens [PDF]

open access: yesRevista de Management Comparat International
This study explores the complex interplay between corruption, economic growth, and logistics performance in EU nations, utilizing a mixed-method approach and data from pre- and post-pandemic periods. Applying the Resource-Based View (RBV) and Qualitative
Alexandra-Codruța BÎZOI (Popescu)   +1 more
doaj   +1 more source

Sofosbuvir-based regimen for genotype 2 HCV infected patients in Taiwan: A real world experience.

open access: yesPLoS ONE, 2020
BackgroundSofosbuvir (SOF)-based regimens achieve excellent efficacy and safety in the treatment of chronic hepatitis C (CHC) with various genotypes. There are few real-world instances of the use of SOF-based regimens to treat genotype 2 CHC.
Wei-Lun Tsai   +5 more
doaj   +1 more source

An Essential Service in Penrose’s Economies of Growth

open access: yesAnnals of Business Administrative Science, 2015
The strategic theory of resource-based view (RBV) put Penrose (1959) in the spotlight. The key to understanding Penrose’s assertion is the concept of economies of growth independent of economies of size.
Nobuo TAKAHASHI
doaj   +1 more source

Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents [PDF]

open access: yes, 2017
Hepatitis C virus (HCV) chronic infection can be associated with extrahepatic manifestations such as mixed cryoglobulinaemia and lymphoproliferative disorders that are endowed with increased rates of morbidity and all-cause mortality.
Burra, Patrizia   +13 more
core   +1 more source

RELATIVE BLOOD VOLUME: THE MEANS OF INTRADIALYSIS HYPOTENSION PREVENTION

open access: yesВестник трансплантологии и искусственных органов, 2010
Intravascular volume preservation is the first choice measure for the prevention of intradialysis hypotension. At present there are devices that allow continuous monitoring of relative blood volume (RBV) changes during haemodialysis (HD). The aim of this
V. A. Terehov, A. G. Strokov
doaj   +1 more source

High Efficacy and Safety of Flat-Dose Ribavirin Plus Sofosbuvir/Daclatasvir in Genotype 3 Cirrhotic Patients

open access: yesGut and Liver, 2020
Background/Aims: Patients with genotype 3 hepatitis C virus (G3-HCV) cirrhosis are very difficult to treat compared to patients with other HCV genotypes. The optimal treatment duration and drug regimen associated with ribavirin (RBV) remain unclear.
Adriano Pellicelli   +21 more
doaj   +1 more source

Assessing partnership alternatives in an IT network employing analytical methods [PDF]

open access: yes, 2016
One of the main critical success factors for the companies is their ability to build and maintain an effective collaborative network. This is more critical in the IT industry where the development of sustainable competitive advantage requires an ...
Aliahmadi, Alireza   +3 more
core   +5 more sources

Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study. [PDF]

open access: yesPLoS ONE, 2015
Ribavirin (RBV) is an essential component of most current hepatitis C (HCV) treatment regimens and still standard of care in the combination with pegylated interferon (pegIFN) to treat chronic HCV in resource limited settings.
Helen Kovari   +13 more
doaj   +1 more source

Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis. [PDF]

open access: yes, 2017
Long-term functional outcomes of sofosbuvir-based antiviral treatment were evaluated in a cohort study involving 16 Italian centres within the international compassionate use programme for post-transplant hepatitis C virus (HCV) recurrence. Seventy-three
Burra, Patrizia   +2 more
core   +1 more source

Establishment of hepatitis C virus RNA-replicating cell lines possessing ribavirin-resistant phenotype.

open access: yesPLoS ONE, 2015
BackgroundRibavirin (RBV) is a potential partner of interferon-based therapy and recently approved therapy using direct acting antivirals for patients with chronic hepatitis C.
Shinya Satoh   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy